Healthcare provider profile · identity verified

Sapna Patel, MD

Family Practice · BURLINGTON, WI · NPI 1649409418

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	432	110
Levothyroxine Sodium	Levothyroxine Sodium	258	62
Amlodipine Besylate	Amlodipine Besylate	233	68
Losartan Potassium	Losartan Potassium	197	57
Omeprazole	Omeprazole	180	48
Rosuvastatin Calcium	Rosuvastatin Calcium	159	37
Metformin Hcl	Metformin Hcl	157	39
Lisinopril	Lisinopril	154	40
Gabapentin	Gabapentin	145	39
Pantoprazole Sodium	Pantoprazole Sodium	142	42
Hydrochlorothiazide	Hydrochlorothiazide	137	37
Metoprolol Succinate	Metoprolol Succinate	128	34
Tramadol Hcl	Tramadol Hcl	111	19
Simvastatin	Simvastatin	105	31
Trazodone Hcl	Trazodone Hcl	91	23
Sertraline Hcl	Sertraline Hcl	88	26
Alendronate Sodium	Alendronate Sodium	87	29
Furosemide	Furosemide	86	31
Baclofen	Baclofen	83	18
Albuterol Sulfate Hfa	Albuterol Sulfate	81	40
Potassium Chloride	Potassium Chloride	76	21
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Pravastatin Sodium	Pravastatin Sodium	68	16
Ozempic	Semaglutide	66	suppressed
Fluticasone Propionate	Fluticasone Propionate	64	31
Carvedilol	Carvedilol	63	16
Glipizide	Glipizide	62	15
Allopurinol	Allopurinol	60	16
Montelukast Sodium	Montelukast Sodium	60	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Famotidine	Famotidine	53	15
Duloxetine Hcl	Duloxetine Hcl	52	18
Pregabalin	Pregabalin	48	14
Glipizide Er	Glipizide	44	12
Alprazolam	Alprazolam	42	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	13
Hydroxyzine Hcl	Hydroxyzine Hcl	41	16
Ketoconazole	Ketoconazole	41	18
Metformin Hcl Er	Metformin Hcl	40	13
Prednisone	Prednisone	39	25
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	11
Symbicort	Budesonide/Formoterol Fumarate	36	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Eliquis	Apixaban	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Spironolactone	Spironolactone	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	13
Propranolol Hcl	Propranolol Hcl	29	suppressed
Topiramate	Topiramate	29	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Lidocaine	Lidocaine	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Invokana	Canagliflozin	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Atenolol	Atenolol	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	19
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Azithromycin	Azithromycin	19	18
Bupropion Xl	Bupropion Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Procto-Med Hc	Hydrocortisone	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	11
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Hydrocortisone	Hydrocortisone	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Diazepam	Diazepam	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Risperidone	Risperidone	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error